Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Bioceltix S.A.

XI3
Current price
14.46 EUR -1.04 EUR (-6.71%)
Last closed 73.8 PLN
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 358 534 501 PLN
Yield for 12 month -8.38 %
1Y
3Y
5Y
10Y
15Y
XI3
21.11.2021 - 28.11.2021

Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. Its products include BCX-CM-J, a stem-cell based biological drug for the treatment of degenerative joint lesions in dogs; BCX-CM-AD, a biological drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a biological drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was incorporated in 2018 and is based in Wroclaw, Poland. Address: Building III, Wroclaw, Poland, 51-317

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1 584.71 PLN

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-1 031 090 PLN

Last Year

-695 282 PLN

Current Quarter

-344 731 PLN

Last Quarter

-234 894 PLN

Key Figures XI3

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -15 079 185 PLN
Operating Margin TTM
PE Ratio
Return On Assets TTM -138.91 %
PEG Ratio
Return On Equity TTM -347.58 %
Wall Street Target Price 1 584.71 PLN
Revenue TTM
Book Value 1.51 PLN
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.74 PLN
Diluted Eps TTM -3.74 PLN
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics XI3

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History XI3

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation XI3

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -18.9897
Price Book MRQ 57.6449

Financials XI3

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators XI3

For 52 weeks

58.01 PLN 97.34 PLN
50 Day MA 70.14 PLN
Shares Short Prior Month
200 Day MA 76.37 PLN
Short Ratio
Shares Short
Short Percent